Chelsea Counsel Company’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.2M Sell
5,420
-1,740
-24% -$706K 1.09% 26
2025
Q1
$3.57M Sell
7,160
-112
-2% -$55.8K 1.94% 14
2024
Q4
$3.79M Sell
7,272
-490
-6% -$255K 1.95% 12
2024
Q3
$4.8M Sell
7,762
-980
-11% -$607K 2.37% 12
2024
Q2
$4.84M Sell
8,742
-8
-0.1% -$4.43K 2.41% 12
2024
Q1
$5.09M Sell
8,750
-240
-3% -$140K 2.89% 11
2023
Q4
$4.77M Sell
8,990
-220
-2% -$117K 2.53% 10
2023
Q3
$4.66M Sell
9,210
-50
-0.5% -$25.3K 2.4% 10
2023
Q2
$4.83M Sell
9,260
-150
-2% -$78.3K 2.38% 11
2023
Q1
$5.43M Sell
9,410
-415
-4% -$239K 2.64% 11
2022
Q4
$5.41M Sell
9,825
-1,683
-15% -$927K 2.7% 11
2022
Q3
$5.84M Sell
11,508
-592
-5% -$300K 3.6% 9
2022
Q2
$6.57M Sell
12,100
-500
-4% -$272K 3.38% 9
2022
Q1
$7.44M Sell
12,600
-750
-6% -$443K 3.28% 9
2021
Q4
$8.91M Sell
13,350
-480
-3% -$320K 3.86% 7
2021
Q3
$7.9M Buy
13,830
+90
+0.7% +$51.4K 3.59% 6
2021
Q2
$6.93M Buy
13,740
+20
+0.1% +$10.1K 3.19% 8
2021
Q1
$6.26M Sell
13,720
-345
-2% -$157K 3.1% 8
2020
Q4
$6.55M Sell
14,065
-2,573
-15% -$1.2M 3.37% 8
2020
Q3
$7.35M Sell
16,638
-1,525
-8% -$673K 4.34% 4
2020
Q2
$6.58M Buy
18,163
+46
+0.3% +$16.7K 4.06% 5
2020
Q1
$5.14M Sell
18,117
-13,445
-43% -$3.81M 4.03% 7
2019
Q4
$10.3M Sell
31,562
-2,677
-8% -$870K 6.24% 4
2019
Q3
$9.97M Sell
34,239
-5,602
-14% -$1.63M 6% 3
2019
Q2
$11.7M Sell
39,841
-215
-0.5% -$63.1K 6.26% 3
2019
Q1
$11M Sell
40,056
-175
-0.4% -$47.9K 5.91% 3
2018
Q4
$9M Sell
40,231
-92
-0.2% -$20.6K 5.46% 4
2018
Q3
$9.84M Buy
40,323
+3,465
+9% +$846K 5.13% 5
2018
Q2
$7.64M Sell
36,858
-3,698
-9% -$766K 4.54% 6
2018
Q1
$8.37M Sell
40,556
-764
-2% -$158K 5.38% 5
2017
Q4
$7.85M Sell
41,320
-5,370
-12% -$1.02M 4.19% 6
2017
Q3
$8.83M Sell
46,690
-775
-2% -$147K 4.42% 6
2017
Q2
$8.28M Sell
47,465
-1,900
-4% -$331K 4.31% 6
2017
Q1
$7.58M Sell
49,365
-900
-2% -$138K 3.9% 6
2016
Q4
$7.09M Buy
50,265
+235
+0.5% +$33.2K 3.73% 5
2016
Q3
$7.96M Buy
50,030
+315
+0.6% +$50.1K 4.07% 5
2016
Q2
$7.35M Buy
49,715
+202
+0.4% +$29.8K 3.32% 5
2016
Q1
$7.01M Buy
49,513
+440
+0.9% +$62.3K 2.26% 12
2015
Q4
$6.96M Sell
49,073
-4,110
-8% -$583K 2.1% 15
2015
Q3
$6.5M Sell
53,183
-930
-2% -$114K 1.55% 23
2015
Q2
$7.02M Buy
54,113
+1,975
+4% +$256K 1.57% 23
2015
Q1
$7M Buy
52,138
+1,245
+2% +$167K 1.51% 23
2014
Q4
$6.38M Sell
50,893
-710
-1% -$89K 1.31% 29
2014
Q3
$6.28M Buy
51,603
+110
+0.2% +$13.4K 1.25% 30
2014
Q2
$6.08M Buy
51,493
+1,320
+3% +$156K 1.19% 31
2014
Q1
$6.03M Buy
50,173
+5,138
+11% +$618K 1.23% 32
2013
Q4
$5.02M Buy
45,035
+1,290
+3% +$144K 1.19% 36
2013
Q3
$4.03M Buy
43,745
+5,760
+15% +$531K 0.84% 42
2013
Q2
$3.22M Buy
+37,985
New +$3.22M 0.84% 41